ALX Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX…
The Perfect Storm: Why Bitcoin Just Broke $70,000 and Where the Bottom Lies
New Global Expansion Report Benchmarks the Hidden Costs and Risks of Scaling Across 19 Markets
cside Launches AI Agent Detection Toolkit, Enabling Websites to Block Agentic Attackers and Guide Agentic Shoppers
Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013